TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Immunovia AB
Closing information (x1000 NOK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
1,596
|
1,083
|
823 |
| Financial expenses |
19,508
|
17,217
|
3,703 |
| Earnings before taxes |
-313,472
|
-159,000
|
-152,102 |
| EBITDA |
-156,758
|
-157,246
|
-143,909 |
| Total assets |
99,967
|
284,331
|
481,574 |
| Current assets |
81,560
|
109,362
|
289,740 |
| Current liabilities |
30,293
|
22,783
|
31,939 |
| Equity capital |
67,864
|
230,616
|
423,152 |
| - share capital |
2,294
|
1,071
|
1,104 |
| Employees (average) |
36
|
64
|
66 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
67.9%
|
81.1%
|
87.9% |
| Turnover per employee |
44
|
17
|
12 |
| Profit as a percentage of turnover |
-19641.1%
|
-14681.4%
|
-18481.4% |
| Return on assets (ROA) |
-294.1%
|
-49.9%
|
-30.8% |
| Current ratio |
269.2%
|
480.0%
|
907.2% |
| Return on equity (ROE) |
-461.9%
|
-68.9%
|
-35.9% |
| Change turnover |
436
|
285
|
470 |
| Change turnover % |
38%
|
36%
|
133% |
| Chg. No. of employees |
-28
|
-2
|
3 |
| Chg. No. of employees % |
-44%
|
-3%
|
5% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.